NextCure Inc reports results for the quarter ended in December - Earnings Summary

NextCure

02/03/2023 22:06

* NextCure Inc  NXTC.OQ  reported a quarterly adjusted loss
of 62
cents​​ per share for the quarter ended in December. The mean
expectation of six analysts for the quarter was for a loss of 66
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * NextCure Inc's reported EPS for the quarter was a loss
of 62
cents​.
    * The mean earnings estimate of analysts had risen by
about 1.4%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * NextCure Inc shares had risen by 11.3% this quarter.
    * The company reported a quarterly loss of $17.3 million.
    * Wall Street's median 12-month price target for NextCure
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 2
at 10:06 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.66          -0.62          Beat
 Sep. 30 2022      -0.63          -0.68          Missed
 Jun. 30 2022      -0.72          -0.65          Beat
 Mar. 31 2022      -0.67          -0.74          Missed